Patents by Inventor John Ryals

John Ryals has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers Related To Metabolic Age and Methods Using The Same
    Publication number: 20100279337
    Abstract: Biomarkers relating to metabolic age are provided, as well as methods for using such biomarkers as biomarkers for determining metabolic age. In addition, methods for modulating the metabolic age of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for metabolic age.
    Type: Application
    Filed: July 13, 2010
    Publication date: November 4, 2010
    Applicant: Metabolon, Inc.
    Inventors: John Ryals, Mike Milburn, Matthew W. Mitchell, Kay A. Lawton
  • Biomarkers related to metabolic age and methods using the same
    Patent number: 7781160
    Abstract: Biomarkers relating to metabolic age are provided, as well as methods for using such biomarkers as biomarkers for determining metabolic age. In addition, methods for modulating the metabolic age of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for metabolic age.
    Type: Grant
    Filed: October 12, 2007
    Date of Patent: August 24, 2010
    Assignee: Metabolon, Inc.
    Inventors: John Ryals, Mike Milburn, Matthew W. Mitchell, Kay A. Lawton
  • Signal sequences for vacuolar sorting
    Patent number: 6054637
    Abstract: The present invention relates to novel peptide fragments [targeting signal] that are obtainable from the C-terminal region [C-terminal extension] of plant vacuole proteins and that, in operable linkage with any desired protein molecule, ensure that the proteins associated with those peptide fragments are directed specifically into the plant vacuole, and to DNA molecules coding for the said peptide fragments.The present invention relates also to recombinant DNA molecules that comprise the DNA sequence according to the invention in operable linkage with an expressible DNA, and to the vectors derived therefrom. Also included are host cells and/or host organisms, including transgenic plants, that comprise the said recombinant DNA or the vectors derived therefrom. The present invention also relates to recombinant DNA molecules and vectors derived therefrom that comprise DNA sequences naturally coding for vacuolar proteins, but which are devoid of vacuole signal sequences and targeted for extracellular secretion.
    Type: Grant
    Filed: October 26, 1994
    Date of Patent: April 25, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Thomas Boller, Jean-Marc Neuhaus, John Ryals